Physician profile
David Loren
NPI 1508825316
$132,113.68
in general payments reported to CMS, 2019-2025
19 companies · $1,987 in 2025
The $1,987 reported for 2025 was more than what 79% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $11K · 2021: $14K · 2022: $23K · 2023: $27K · 2024: $18K · 2025: $1,987.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $4,234 · Travel and Lodging: $4,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,412.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,750.00 |
| Food and Beverage | $4,234.41 |
| Travel and Lodging | $4,008.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $59,642.73 | 2019-2025 | Axios, Apollo Esg Nxt System, Exalt Model D |
| Olympus Corporation | $27,400.25 | 2019-2024 | |
| Olympus America INC. | $21,492.15 | 2019-2025 | Visiglide |
| Olympus Latin America, INC. | $14,878.60 | 2019-2020 | |
| Pinnacle Biologics, INC | $3,500.00 | 2021 | |
| Olympus Corporation of The Americas | $1,891.70 | 2023-2024 | Evis Exera III Colonovideoscope, Olympus |
| Fujifilm Healthcare Americas Corporation | $1,534.81 | 2020-2025 | Fujifilm |
| Ambu INC. | $529.53 | 2021 | |
| Medtronic, INC. | $381.70 | 2022 | |
| Angiodynamics, INC. | $192.37 | 2022 | |
| Apollo Endosurgery US INC | $135.57 | 2022 | |
| Covidien LP | $132.39 | 2019 | |
| Atricure, INC. | $124.02 | 2019 | |
| Endogastric Solutions, INC | $105.95 | 2023 | Esophyx |
| Astrazeneca Pharmaceuticals LP | $84.35 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $33.59 | 2024 | |
| Galvanize Therapeutics, INC | $21.04 | 2025 | Aliya System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.93 | 2019 | |
| Erbe USA INC | $15.00 | 2025 | Vio3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Loren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.